Connect with us


Cabot Marijuana Investor: What’s “Strongest Stock” in the Cannabis Industry?



Cabot Marijuana Investor: What's "Strongest Stock" in the Cannabis Industry?

The market is not doing well right now at all, and many investors are becoming nervous over what this means for their own investments. Though the end of 2019 didn’t bring much good news about marijuana investments, the researchers at Cabot Wealth Network aren’t worried at all. In fact, they are bringing forth an opportunity to invest that will allow consumers to capitalize on their growing profit.

The creators plainly state that there’s a certain technique to stock investments – “make a lot more money than others when the market is going up, and … move to cash and carefully buy bargains when the market is down.” By using this strategy, the creators believe that it will continually help the participate to “stay rich.” While there are many headlines in the world today on marijuana stocks being bad investments, Tim Lutts believes that this news is old and no longer relevant.

For example, from October 2017 to January 2018, an annual rate of return of 872% was recorded after the North American Marijuana Index surged by over 200%. Events like exactly this circumstance are what Tim warned his subscribers about, giving them the opportunity to make big money. By subscribing to his newsletter, other opportunities will arise that investors will have early access to investments that will help to grow their profits exponentially.

Cabot Wealth Network was originally founded by Tim’s father, Carlton Lutts Jr., in 1970, and the analysts with the company have been frequently praised for their ability to pick these stocks for consumers. In fact, in the last 50 years since the company was created, clients’ funds have been doubled over 200 times. With Cabot Marijuana Investor, consumers are able to reap the investigative benefits of this portfolio, even though it was only created about two years ago.

Subscribing to Cabot Marijuana Investor

To enroll in the Cabot Marijuana Investor subscription, the total cost is $497.00 per year, though there is also the option to pay installments of $49.97 each month. Every subscriber will be updated monthly on the changes in the market, including any government regulations or earnings releases that could impact the investments. This subscription is the only way to get updates and access to the Cabot Marijuana Investor website, as well as a direct email address to Tim to discuss the forecasts and recommendations.

With the subscription, consumers will also get a free copy of a report called The Apple of Cannabis. This report describes the history of the company that the creators urges investors to get involved with. It also discusses how to buy the stock, which comes with a financial analysis, technical analysis, and business analysis.

Need Help?

Though consumers will be given access to a private email after enrolling, there are some individuals that will want to get more information before they get started. The customer service team for the Cabot Health Network can be reached by calling 800-326-8826.

Electronic inquiries can be submitted by filling out the form at

Abby Veronika is one of the leading researchers here and resides in Southern California where she is a student at a local college to study Communications. While she is a best-selling women’s romance novel author on Amazon, her real expertise and passion lives within the cannabis, health and nutrition space.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.